DK130991B - Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater. - Google Patents

Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater.

Info

Publication number
DK130991B
DK130991B DK613670AA DK613670A DK130991B DK 130991 B DK130991 B DK 130991B DK 613670A A DK613670A A DK 613670AA DK 613670 A DK613670 A DK 613670A DK 130991 B DK130991 B DK 130991B
Authority
DK
Denmark
Prior art keywords
16beta
9alpha
11beta
pregnadiene
17alpha
Prior art date
Application number
DK613670AA
Other languages
English (en)
Other versions
DK130991C (da
Inventor
I Villax
Original Assignee
I Villax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I Villax filed Critical I Villax
Publication of DK130991B publication Critical patent/DK130991B/da
Application granted granted Critical
Publication of DK130991C publication Critical patent/DK130991C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Table Devices Or Equipment (AREA)
DK613670AA 1969-12-13 1970-12-02 Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater. DK130991B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT5292369 1969-12-13

Publications (2)

Publication Number Publication Date
DK130991B true DK130991B (da) 1975-05-12
DK130991C DK130991C (da) 1975-12-08

Family

ID=20081704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK613670AA DK130991B (da) 1969-12-13 1970-12-02 Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater.

Country Status (15)

Country Link
US (1) US3792046A (da)
JP (3) JPS508080B1 (da)
AT (1) AT304774B (da)
BE (1) BE760236A (da)
CA (1) CA932321A (da)
CH (1) CH551395A (da)
DE (1) DE2059050A1 (da)
DK (1) DK130991B (da)
ES (1) ES386385A1 (da)
FR (1) FR2081356B1 (da)
GB (1) GB1328998A (da)
IL (3) IL35823A (da)
NL (1) NL166694C (da)
NO (1) NO136049C (da)
ZA (1) ZA708393B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58212359A (ja) * 1982-05-25 1983-12-10 マグネツト・モ−トル・ゲゼルシヤフト・フユア・マグネツトモ−トリツシエ・テクニ−ク・ミツト・ベシユレンクテル・ハフツンク 回転電気機械
JPS6261175U (da) * 1985-10-02 1987-04-16
JPS62135570U (da) * 1986-02-19 1987-08-26
JP2004536088A (ja) * 2001-06-18 2004-12-02 ファルマシア・アンド・アップジョン・カンパニー １１β，１７α，２１−トリヒドロキシ−６α−メチルプレグナ−１，４−ジエン−３，２０−ジオン２１−アセテートの製法
US20040006240A1 (en) * 2001-06-18 2004-01-08 Pearlman Bruce Allen Process to prepare 11beta,17alpha ,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
CN101555268B (zh) * 2009-05-21 2011-11-30 广西万德药业股份有限公司 一种糖皮质激素类9，11环氧物中间体制备方法
CN102304163A (zh) * 2011-07-11 2012-01-04 浙江仙居仙乐药业有限公司 一种倍他米松上氟合成方法
CN104945464B (zh) * 2015-04-17 2016-10-26 浙江仙居仙乐药业有限公司 一种倍他米松环氧水解物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274397A (fr) * 1958-12-16 1961-10-27 Chimiotherapie Lab Franc Procédé de préparation de dérivés 9alpha-fluoro 16alpha-méthyl delta1, 4-pregnadiènes
FR1243528A (fr) * 1959-08-05 1960-10-14 Chimiotherapie Lab Franc Procédé d'acétoxylation de stéroïdes en 21 par l'intermédiaire de dérivés diiodés

Also Published As

Publication number Publication date
NO136049C (no) 1977-07-13
JPS508080B1 (da) 1975-04-01
FR2081356A1 (da) 1971-12-03
NL7017904A (da) 1971-06-15
NL166694B (nl) 1981-04-15
GB1328998A (en) 1973-09-05
JPS5721280B1 (da) 1982-05-06
NO136049B (da) 1977-04-04
BE760236A (fr) 1971-05-17
FR2081356B1 (da) 1976-09-17
JPS5721279B1 (da) 1982-05-06
ES386385A1 (es) 1973-03-16
IL35823A0 (en) 1971-02-25
DE2059050A1 (de) 1972-04-06
CH551395A (de) 1974-07-15
US3792046A (en) 1974-02-12
ZA708393B (en) 1972-07-26
DK130991C (da) 1975-12-08
NL166694C (nl) 1981-09-15
CA932321A (en) 1973-08-21
AT304774B (de) 1973-01-25
IL35823A (en) 1977-08-31
IL49763A0 (en) 1976-08-31
IL49763A (en) 1977-08-31

Similar Documents

Publication Publication Date Title
DK129988B (da) Fremgangsmåde til fremstilling af 17-monoestere af 17α,21-dihydroxy-20-keto-steroidforbindelser af pregnanrækken.
DK125086B (da) Fremgangsmåde til fremstilling af 11β,17α-dihydroxysteroider af pregnanrækken eller 17α-carboxylsyreestere deraf.
DK130991B (da) Fremgangsmåde til fremstilling af 16beta-metyl-9alfa-fluor-11beta-17alfa,21-trihydroxy-1,4-pregnadien-3,20-dion eller dets 21-acylater.
DK129704B (da) Fremgangsmåde til fremstilling af 17α-klor-6α-fluor-16α-methylpregna-1,4-dien-3,20-dion-21-oler eller estere deraf.
DK128352B (da) Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.
DK136218B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken.
DK129039B (da) Fremgangsmåde til fremstilling af 11β,16α17α21-tetrahydroxy-pregna-1,4-dien-3,20-dioner eller de tilsvarende 16,17-acetonider.
DK111678B (da) Fremgangsmåde til fremstilling af 3,6-dioxo-17α-ethyl-17β-hydroxy-A-nor-B-homo-10-ξ-estran og dets enolformer eller 17-estere deraf.
DK123713B (da) Analogifremgangsmåde til fremstilling af 21-estere af corticosteroider eller syreadditionssalte deraf.
DK122454B (da) Fremgangsmåde til fremstilling af 9α,21,21-triklor-11β-fluor-pregn-4-en-3,20-dioner.
DK127420B (da) Analogifremgangsmåde til fremstilling af 6α-fluor-16α,18-dimethyl-1,4-pregnadien-3,20-dionderivater.
DK125244B (da) Fremgangsmåde til fremstilling af 9α-fluor-16-methyl-prednisolon eller -prednison eller 21-estere deraf.
DK127924B (da) Analogifremgangsmåde til fremstilling af 7α-methyl-3,16α,17β-trihydroxy-Δ1,3,5(10)-estratrien.
DK124539B (da) Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken.
DK130646B (da) Analogifremgangsmåde til fremstilling af 17- og/eller 21-alkanoyloxy-11beta-klor-16beta-metylpregna-1,4-dien-3,20-dioner.
DK120235B (da) Analogifremgangsmåde til fremstilling af 9α, 11β-disubstituerede 6α-fluor-16α-methyl-21-halogen-4-pregnen-3,20-dionderivater.
DK106494C (da) Fremgangsmåde til fremstilling af 11β-hydroxy-17α-ethinylestradiol eller dets 3-estere eller 3-ethere.
DK122812B (da) Analogifremgangsmåde til fremstilling af 9α-fluor-11β,21-dihydroxy-16α-17α-(2-propenylidendioxy)-pregna-1,4-dien-3,20-dion eller 21-estere deraf.
DK111141B (da) Fremgangsmåde til fremstilling af 2'-acetamido-2'-desoxyglucosider eller -galactosider af 17α,21-dihydroxy-11-oxygenerede -3,20-diketo-steroider af pregnanrækken.
DK126937B (da) Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK134071B (da) Fremgangsmåde til selektiv 9(11)-enolisering eller enolforestring af steroid-1,4-dien-3,11-dioner.
DK129452B (da) Analogifremgangsmåde til fremstilling af 9α-fluor-11β,21-dihydroxy-pregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidiner eller oxazolidinooxaziner.
DK112381B (da) Fremgangsmåde til fremstilling af 16-fluormethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-nor-pregnan- eller iso-pregnanrækken eller 17α-estere deraf.
DK113920B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 21-(β-ethoxy-ethoxy)-acetater eller 21-(β-ethoxy-β-ethoxy-ethoxy)-acetater af steroider af pregnanrækken.